Cargando…
COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis
A 40-year-old man was admitted to our hospital for COVID-19. He had been treated for essential thrombocythemia (ET). He was diagnosed severe illness of COVID-19, oxygen therapy and dexamethasone were administered. There was a possibility of thromboembolic events in this case, apixaban for prophylaxi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634247/ https://www.ncbi.nlm.nih.gov/pubmed/34848425 http://dx.doi.org/10.1136/bcr-2021-246700 |